AesMed Interview on AVING NEWS

AesMed Interview on AVING NEWS | Exclusive Insights on Hair Restoration Innovations at interCHARM KOREA 2025

AesMed is proud to announce our participation in interCHARM KOREA 2025, one of the most influential beauty and wellness trade shows in Asia, and to share our exclusive interview featured on AVING NEWS.
This exciting opportunity allowed us to showcase our innovative solutions for hair restoration and highlight our continued leadership in the field of cytokines therapy for alopecia.

During the interview, AesMed’s experts provided valuable insights into our flagship treatments—CytoMesopecia and AGF39™.
These groundbreaking cytokine-based therapies have become essential solutions for hair loss treatment in Korea and Japan, offering patients safe and effective methods for hair follicle regeneration and scalp health improvement.

The discussion also focused on our participation in interCHARM KOREA 2025, where AesMed introduced its innovations in hair restoration, met with global buyers and dermatology professionals, and explored potential international partnerships.

We invite you to watch the full interview and learn more about our journey in transforming hair restoration through cutting-edge technology and cytokines therapies.

Watch the full interview here:

AesMed Interview on AVING NEWS at interCHARM KOREA 2025
As we continue to lead the field in Cytokines Therapy for Alopecia, we look forward to further advancements in our research and innovations and to making a meaningful difference in the lives of those affected by hair loss.

Stay tuned for more updates as we continue to push the boundaries of hair restoration.